Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and raphe nuclei
The effects of a neonatal dopaminergic deafferentation with the neurotoxin 6‐hydroxydopamine (6‐OHDA) on endogenous tissue levels of catecholamines, indoleamines, and amino acids were investigated in discrete rat brain regions. After producing the lesion at postnatal day 3 by intraventricular inject...
Gespeichert in:
Veröffentlicht in: | Journal of neuroscience research 1993-07, Vol.35 (4), p.409-418 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 418 |
---|---|
container_issue | 4 |
container_start_page | 409 |
container_title | Journal of neuroscience research |
container_volume | 35 |
creator | Molina-Holgado, E. Dewar, K. M. Grondin, L van Gelder, N. M. Reader, T. A. |
description | The effects of a neonatal dopaminergic deafferentation with the neurotoxin 6‐hydroxydopamine (6‐OHDA) on endogenous tissue levels of catecholamines, indoleamines, and amino acids were investigated in discrete rat brain regions. After producing the lesion at postnatal day 3 by intraventricular injections of 6‐OHDA, with a desipramine pretreatment to protect noradrenaline neurons, the animals were kept for 3 months. Their brains were dissected to obtain samples of neostriatum, Globus pallidus, Substantia nigra, and Raphe nuclei, which were then analyzed by high‐performance liquid chromatography, coupled either to electrochemical detection for aromatic monoamines, or to post‐column ninhydrin derivatization with spectrophotometry for amino acids. The neonatal 6‐OHDA treatment depleted dopamine (DA) levels in neostriatum, Globus pallidus, and Substantia nigra, but in Raphe nuclei DA was increased. The main metabolites of DA were also decreased in neostriatum, Globus pallidus, and Substantia nigra but remained unchanged in Raphe nuclei. Serotonin (5‐HT) and its metabolite 5‐hydroxyindole‐3‐acetic acid increased in neostriatum and Raphe nuclei; in Substantia nigra there was a slight increase in 5‐HT only. The 6‐OHDA lesion caused heterogeneous alterations in amino acid contents, which varied according to the region. In the neostriatum there were increases of γ‐aminobutyric acid (GABA), aspartic acid, and glycine. In the Globus pallidus taurine, GABA, glutamic acid, glutamine, aspartic acid, serine, and alanine were elevated. In the Substantia nigra only increases in taurine, GABA, glutamic acid, and glutamine could be documented. This study shows important changes in amino acid levels and in some of their ratios, occurring in different anatomical subdivisions of the basal ganglia and related brainstem nuclei following a neonatal treatment with 6‐OHDA. The results thus demonstrate major biochemical modifications in amino acids in the aftermath of a DA denervation and/or a 5‐HT hyperinnervation during an early developmental period. © 1993 Wiley‐Liss, Inc. |
doi_str_mv | 10.1002/jnr.490350408 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16661323</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16661323</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5298-fcab972ef62448cd9bceaaa01726bc0dea9e17f033050cfb9465b03a5bbbd553</originalsourceid><addsrcrecordid>eNp9kUFv1DAQhSMEKkvhyBHJB8SpKePYSdZHWNEtVSkSqlSJizV2JrsuWWdrJ6X7L_jJeLXRihOnkeZ9M2_sl2VvOZxzgOLjvQ_nUoEoQcL8WTbjoOpclrJ-ns1AVJBL4MXL7FWM9wCgVClOspN5EpRUs-zPYo1-RZH1LcON8z1D6xqGvmGb3vf7FrGOHqmLDNuBAvPUexywY1W-3jWhf9o1_fbANeQpPOLges-cZwEHZjAmdJU8OodnLI4mDugHh8y7VUidvVPA7ZqYH21H7nX2osUu0pupnma3F19uF5f59ffl18Wn69yWhZrnrUWj6oLaqpBybhtlLCEi8LqojIWGUBGvWxACSrCtUbIqDQgsjTFNWYrT7MNh7Tb0DyPFQW9ctNR1mN43Rs2rquKiEAnMD6ANfYyBWr0NboNhpznofQA6BaCPAST-3bR4NBtqjvT040l_P-kYLXZtQG9dPGKyVpwDT1h9wH67jnb_99RXNz_-PWA62MWBno6TGH7pqhZ1qe9ulhp-Lj9fXYpv-k78BbBXsHk</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16661323</pqid></control><display><type>article</type><title>Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and raphe nuclei</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Molina-Holgado, E. ; Dewar, K. M. ; Grondin, L ; van Gelder, N. M. ; Reader, T. A.</creator><creatorcontrib>Molina-Holgado, E. ; Dewar, K. M. ; Grondin, L ; van Gelder, N. M. ; Reader, T. A.</creatorcontrib><description>The effects of a neonatal dopaminergic deafferentation with the neurotoxin 6‐hydroxydopamine (6‐OHDA) on endogenous tissue levels of catecholamines, indoleamines, and amino acids were investigated in discrete rat brain regions. After producing the lesion at postnatal day 3 by intraventricular injections of 6‐OHDA, with a desipramine pretreatment to protect noradrenaline neurons, the animals were kept for 3 months. Their brains were dissected to obtain samples of neostriatum, Globus pallidus, Substantia nigra, and Raphe nuclei, which were then analyzed by high‐performance liquid chromatography, coupled either to electrochemical detection for aromatic monoamines, or to post‐column ninhydrin derivatization with spectrophotometry for amino acids. The neonatal 6‐OHDA treatment depleted dopamine (DA) levels in neostriatum, Globus pallidus, and Substantia nigra, but in Raphe nuclei DA was increased. The main metabolites of DA were also decreased in neostriatum, Globus pallidus, and Substantia nigra but remained unchanged in Raphe nuclei. Serotonin (5‐HT) and its metabolite 5‐hydroxyindole‐3‐acetic acid increased in neostriatum and Raphe nuclei; in Substantia nigra there was a slight increase in 5‐HT only. The 6‐OHDA lesion caused heterogeneous alterations in amino acid contents, which varied according to the region. In the neostriatum there were increases of γ‐aminobutyric acid (GABA), aspartic acid, and glycine. In the Globus pallidus taurine, GABA, glutamic acid, glutamine, aspartic acid, serine, and alanine were elevated. In the Substantia nigra only increases in taurine, GABA, glutamic acid, and glutamine could be documented. This study shows important changes in amino acid levels and in some of their ratios, occurring in different anatomical subdivisions of the basal ganglia and related brainstem nuclei following a neonatal treatment with 6‐OHDA. The results thus demonstrate major biochemical modifications in amino acids in the aftermath of a DA denervation and/or a 5‐HT hyperinnervation during an early developmental period. © 1993 Wiley‐Liss, Inc.</description><identifier>ISSN: 0360-4012</identifier><identifier>EISSN: 1097-4547</identifier><identifier>DOI: 10.1002/jnr.490350408</identifier><identifier>PMID: 8360949</identifier><identifier>CODEN: JNREDK</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Amino Acids - metabolism ; Animals ; Animals, Newborn - metabolism ; Basal Ganglia - drug effects ; Basal Ganglia - metabolism ; Biochemistry and metabolism ; Biogenic Monoamines - metabolism ; Biological and medical sciences ; Catecholamines - metabolism ; Central nervous system ; Chromatography, High Pressure Liquid ; Denervation ; dopamine ; Dopamine - physiology ; Female ; Fundamental and applied biological sciences. Psychology ; GABA ; gamma-Aminobutyric Acid - physiology ; HPLC ; Injections, Intraventricular ; metabolites ; neostriatum ; Neostriatum - drug effects ; Neostriatum - metabolism ; Neurons, Efferent - drug effects ; Neurons, Efferent - metabolism ; Oxidopamine - administration & dosage ; Oxidopamine - pharmacology ; Pregnancy ; Raphe Nuclei - drug effects ; Raphe Nuclei - metabolism ; Rats ; Rats, Sprague-Dawley ; serotonin ; Serotonin - metabolism ; Substantia Nigra - drug effects ; Substantia Nigra - metabolism ; Vertebrates: nervous system and sense organs</subject><ispartof>Journal of neuroscience research, 1993-07, Vol.35 (4), p.409-418</ispartof><rights>Copyright © 1993 Wiley‐Liss, Inc.</rights><rights>1993 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5298-fcab972ef62448cd9bceaaa01726bc0dea9e17f033050cfb9465b03a5bbbd553</citedby><cites>FETCH-LOGICAL-c5298-fcab972ef62448cd9bceaaa01726bc0dea9e17f033050cfb9465b03a5bbbd553</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjnr.490350408$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjnr.490350408$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,776,780,1411,27903,27904,45553,45554</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=4791101$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8360949$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Molina-Holgado, E.</creatorcontrib><creatorcontrib>Dewar, K. M.</creatorcontrib><creatorcontrib>Grondin, L</creatorcontrib><creatorcontrib>van Gelder, N. M.</creatorcontrib><creatorcontrib>Reader, T. A.</creatorcontrib><title>Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and raphe nuclei</title><title>Journal of neuroscience research</title><addtitle>J. Neurosci. Res</addtitle><description>The effects of a neonatal dopaminergic deafferentation with the neurotoxin 6‐hydroxydopamine (6‐OHDA) on endogenous tissue levels of catecholamines, indoleamines, and amino acids were investigated in discrete rat brain regions. After producing the lesion at postnatal day 3 by intraventricular injections of 6‐OHDA, with a desipramine pretreatment to protect noradrenaline neurons, the animals were kept for 3 months. Their brains were dissected to obtain samples of neostriatum, Globus pallidus, Substantia nigra, and Raphe nuclei, which were then analyzed by high‐performance liquid chromatography, coupled either to electrochemical detection for aromatic monoamines, or to post‐column ninhydrin derivatization with spectrophotometry for amino acids. The neonatal 6‐OHDA treatment depleted dopamine (DA) levels in neostriatum, Globus pallidus, and Substantia nigra, but in Raphe nuclei DA was increased. The main metabolites of DA were also decreased in neostriatum, Globus pallidus, and Substantia nigra but remained unchanged in Raphe nuclei. Serotonin (5‐HT) and its metabolite 5‐hydroxyindole‐3‐acetic acid increased in neostriatum and Raphe nuclei; in Substantia nigra there was a slight increase in 5‐HT only. The 6‐OHDA lesion caused heterogeneous alterations in amino acid contents, which varied according to the region. In the neostriatum there were increases of γ‐aminobutyric acid (GABA), aspartic acid, and glycine. In the Globus pallidus taurine, GABA, glutamic acid, glutamine, aspartic acid, serine, and alanine were elevated. In the Substantia nigra only increases in taurine, GABA, glutamic acid, and glutamine could be documented. This study shows important changes in amino acid levels and in some of their ratios, occurring in different anatomical subdivisions of the basal ganglia and related brainstem nuclei following a neonatal treatment with 6‐OHDA. The results thus demonstrate major biochemical modifications in amino acids in the aftermath of a DA denervation and/or a 5‐HT hyperinnervation during an early developmental period. © 1993 Wiley‐Liss, Inc.</description><subject>Amino Acids - metabolism</subject><subject>Animals</subject><subject>Animals, Newborn - metabolism</subject><subject>Basal Ganglia - drug effects</subject><subject>Basal Ganglia - metabolism</subject><subject>Biochemistry and metabolism</subject><subject>Biogenic Monoamines - metabolism</subject><subject>Biological and medical sciences</subject><subject>Catecholamines - metabolism</subject><subject>Central nervous system</subject><subject>Chromatography, High Pressure Liquid</subject><subject>Denervation</subject><subject>dopamine</subject><subject>Dopamine - physiology</subject><subject>Female</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>GABA</subject><subject>gamma-Aminobutyric Acid - physiology</subject><subject>HPLC</subject><subject>Injections, Intraventricular</subject><subject>metabolites</subject><subject>neostriatum</subject><subject>Neostriatum - drug effects</subject><subject>Neostriatum - metabolism</subject><subject>Neurons, Efferent - drug effects</subject><subject>Neurons, Efferent - metabolism</subject><subject>Oxidopamine - administration & dosage</subject><subject>Oxidopamine - pharmacology</subject><subject>Pregnancy</subject><subject>Raphe Nuclei - drug effects</subject><subject>Raphe Nuclei - metabolism</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>serotonin</subject><subject>Serotonin - metabolism</subject><subject>Substantia Nigra - drug effects</subject><subject>Substantia Nigra - metabolism</subject><subject>Vertebrates: nervous system and sense organs</subject><issn>0360-4012</issn><issn>1097-4547</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1993</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUFv1DAQhSMEKkvhyBHJB8SpKePYSdZHWNEtVSkSqlSJizV2JrsuWWdrJ6X7L_jJeLXRihOnkeZ9M2_sl2VvOZxzgOLjvQ_nUoEoQcL8WTbjoOpclrJ-ns1AVJBL4MXL7FWM9wCgVClOspN5EpRUs-zPYo1-RZH1LcON8z1D6xqGvmGb3vf7FrGOHqmLDNuBAvPUexywY1W-3jWhf9o1_fbANeQpPOLges-cZwEHZjAmdJU8OodnLI4mDugHh8y7VUidvVPA7ZqYH21H7nX2osUu0pupnma3F19uF5f59ffl18Wn69yWhZrnrUWj6oLaqpBybhtlLCEi8LqojIWGUBGvWxACSrCtUbIqDQgsjTFNWYrT7MNh7Tb0DyPFQW9ctNR1mN43Rs2rquKiEAnMD6ANfYyBWr0NboNhpznofQA6BaCPAST-3bR4NBtqjvT040l_P-kYLXZtQG9dPGKyVpwDT1h9wH67jnb_99RXNz_-PWA62MWBno6TGH7pqhZ1qe9ulhp-Lj9fXYpv-k78BbBXsHk</recordid><startdate>19930701</startdate><enddate>19930701</enddate><creator>Molina-Holgado, E.</creator><creator>Dewar, K. M.</creator><creator>Grondin, L</creator><creator>van Gelder, N. M.</creator><creator>Reader, T. A.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley-Liss</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope></search><sort><creationdate>19930701</creationdate><title>Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and raphe nuclei</title><author>Molina-Holgado, E. ; Dewar, K. M. ; Grondin, L ; van Gelder, N. M. ; Reader, T. A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5298-fcab972ef62448cd9bceaaa01726bc0dea9e17f033050cfb9465b03a5bbbd553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1993</creationdate><topic>Amino Acids - metabolism</topic><topic>Animals</topic><topic>Animals, Newborn - metabolism</topic><topic>Basal Ganglia - drug effects</topic><topic>Basal Ganglia - metabolism</topic><topic>Biochemistry and metabolism</topic><topic>Biogenic Monoamines - metabolism</topic><topic>Biological and medical sciences</topic><topic>Catecholamines - metabolism</topic><topic>Central nervous system</topic><topic>Chromatography, High Pressure Liquid</topic><topic>Denervation</topic><topic>dopamine</topic><topic>Dopamine - physiology</topic><topic>Female</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>GABA</topic><topic>gamma-Aminobutyric Acid - physiology</topic><topic>HPLC</topic><topic>Injections, Intraventricular</topic><topic>metabolites</topic><topic>neostriatum</topic><topic>Neostriatum - drug effects</topic><topic>Neostriatum - metabolism</topic><topic>Neurons, Efferent - drug effects</topic><topic>Neurons, Efferent - metabolism</topic><topic>Oxidopamine - administration & dosage</topic><topic>Oxidopamine - pharmacology</topic><topic>Pregnancy</topic><topic>Raphe Nuclei - drug effects</topic><topic>Raphe Nuclei - metabolism</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>serotonin</topic><topic>Serotonin - metabolism</topic><topic>Substantia Nigra - drug effects</topic><topic>Substantia Nigra - metabolism</topic><topic>Vertebrates: nervous system and sense organs</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Molina-Holgado, E.</creatorcontrib><creatorcontrib>Dewar, K. M.</creatorcontrib><creatorcontrib>Grondin, L</creatorcontrib><creatorcontrib>van Gelder, N. M.</creatorcontrib><creatorcontrib>Reader, T. A.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><jtitle>Journal of neuroscience research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Molina-Holgado, E.</au><au>Dewar, K. M.</au><au>Grondin, L</au><au>van Gelder, N. M.</au><au>Reader, T. A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and raphe nuclei</atitle><jtitle>Journal of neuroscience research</jtitle><addtitle>J. Neurosci. Res</addtitle><date>1993-07-01</date><risdate>1993</risdate><volume>35</volume><issue>4</issue><spage>409</spage><epage>418</epage><pages>409-418</pages><issn>0360-4012</issn><eissn>1097-4547</eissn><coden>JNREDK</coden><abstract>The effects of a neonatal dopaminergic deafferentation with the neurotoxin 6‐hydroxydopamine (6‐OHDA) on endogenous tissue levels of catecholamines, indoleamines, and amino acids were investigated in discrete rat brain regions. After producing the lesion at postnatal day 3 by intraventricular injections of 6‐OHDA, with a desipramine pretreatment to protect noradrenaline neurons, the animals were kept for 3 months. Their brains were dissected to obtain samples of neostriatum, Globus pallidus, Substantia nigra, and Raphe nuclei, which were then analyzed by high‐performance liquid chromatography, coupled either to electrochemical detection for aromatic monoamines, or to post‐column ninhydrin derivatization with spectrophotometry for amino acids. The neonatal 6‐OHDA treatment depleted dopamine (DA) levels in neostriatum, Globus pallidus, and Substantia nigra, but in Raphe nuclei DA was increased. The main metabolites of DA were also decreased in neostriatum, Globus pallidus, and Substantia nigra but remained unchanged in Raphe nuclei. Serotonin (5‐HT) and its metabolite 5‐hydroxyindole‐3‐acetic acid increased in neostriatum and Raphe nuclei; in Substantia nigra there was a slight increase in 5‐HT only. The 6‐OHDA lesion caused heterogeneous alterations in amino acid contents, which varied according to the region. In the neostriatum there were increases of γ‐aminobutyric acid (GABA), aspartic acid, and glycine. In the Globus pallidus taurine, GABA, glutamic acid, glutamine, aspartic acid, serine, and alanine were elevated. In the Substantia nigra only increases in taurine, GABA, glutamic acid, and glutamine could be documented. This study shows important changes in amino acid levels and in some of their ratios, occurring in different anatomical subdivisions of the basal ganglia and related brainstem nuclei following a neonatal treatment with 6‐OHDA. The results thus demonstrate major biochemical modifications in amino acids in the aftermath of a DA denervation and/or a 5‐HT hyperinnervation during an early developmental period. © 1993 Wiley‐Liss, Inc.</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>8360949</pmid><doi>10.1002/jnr.490350408</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0360-4012 |
ispartof | Journal of neuroscience research, 1993-07, Vol.35 (4), p.409-418 |
issn | 0360-4012 1097-4547 |
language | eng |
recordid | cdi_proquest_miscellaneous_16661323 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Amino Acids - metabolism Animals Animals, Newborn - metabolism Basal Ganglia - drug effects Basal Ganglia - metabolism Biochemistry and metabolism Biogenic Monoamines - metabolism Biological and medical sciences Catecholamines - metabolism Central nervous system Chromatography, High Pressure Liquid Denervation dopamine Dopamine - physiology Female Fundamental and applied biological sciences. Psychology GABA gamma-Aminobutyric Acid - physiology HPLC Injections, Intraventricular metabolites neostriatum Neostriatum - drug effects Neostriatum - metabolism Neurons, Efferent - drug effects Neurons, Efferent - metabolism Oxidopamine - administration & dosage Oxidopamine - pharmacology Pregnancy Raphe Nuclei - drug effects Raphe Nuclei - metabolism Rats Rats, Sprague-Dawley serotonin Serotonin - metabolism Substantia Nigra - drug effects Substantia Nigra - metabolism Vertebrates: nervous system and sense organs |
title | Changes of amino acid and monoamine levels after neonatal 6-hydroxydopamine denervation in rat basal ganglia, substantia nigra, and raphe nuclei |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T15%3A02%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Changes%20of%20amino%20acid%20and%20monoamine%20levels%20after%20neonatal%206-hydroxydopamine%20denervation%20in%20rat%20basal%20ganglia,%20substantia%20nigra,%20and%20raphe%20nuclei&rft.jtitle=Journal%20of%20neuroscience%20research&rft.au=Molina-Holgado,%20E.&rft.date=1993-07-01&rft.volume=35&rft.issue=4&rft.spage=409&rft.epage=418&rft.pages=409-418&rft.issn=0360-4012&rft.eissn=1097-4547&rft.coden=JNREDK&rft_id=info:doi/10.1002/jnr.490350408&rft_dat=%3Cproquest_cross%3E16661323%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16661323&rft_id=info:pmid/8360949&rfr_iscdi=true |